BRAF and Langerhans cell histiocytosis: Allogenic haematopoietic stem cell transplant may be considered as salvage therapy in treatment-resistant LCH, and targeted therapy with BRAF inhibitors can be considered in multisystemic disease with CNS involvement (7).